rs587777161
Variant summary
Our verdict is Pathogenic. Variant got 23 ACMG points: 23P and 0B. PS1PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The ENST00000380833.9(CLCN4):c.1630G>A(p.Gly544Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/20 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Pathogenicin ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G544E) has been classified as Pathogenic.
Frequency
Consequence
ENST00000380833.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 23 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CLCN4 | NM_001830.4 | c.1630G>A | p.Gly544Arg | missense_variant | 11/13 | ENST00000380833.9 | NP_001821.2 | |
CLCN4 | NM_001256944.2 | c.1348G>A | p.Gly450Arg | missense_variant | 9/11 | NP_001243873.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CLCN4 | ENST00000380833.9 | c.1630G>A | p.Gly544Arg | missense_variant | 11/13 | 1 | NM_001830.4 | ENSP00000370213 | P4 |
Frequencies
GnomAD3 genomes Cov.: 24
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 24
ClinVar
Submissions by phenotype
Intellectual disability, X-linked 49 Pathogenic:3
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 01, 2013 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | 3billion | - | The variant is not observed in the gnomAD v2.1.1 dataset. Missense changes are a common disease-causing mechanism. In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.88; 3Cnet: 0.99). Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000100781 / PMID: 23647072). The variant has been previously reported as de novo in a similarly affected individual (PMID: 23647072). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. - |
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics, University of Leipzig Medical Center | Jul 04, 2022 | This variant was identified as hemizygous._x000D_ Criteria applied: PS1, PS2, PM1, PS4_SUP, PM2_SUP, PP3 - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Sep 22, 2021 | Published functional studies demonstrate an almost abolishment of ClC-4 currents that lead to a damaging effect (Veeramah et al., 2013); Not observed in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 23647072, 27550844) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at